NCT02851641View on ClinicalTrials.gov

Risk and Importance of Peroperative Nasal Hemorrhage in the Treatment of Lacrimal Duct Obstruction in Young Children

CompletedOBSERVATIONAL

Enrollment

108

Participants

Timeline

Start Date

September 2, 2015

Primary Completion Date

September 11, 2019

Study Completion Date

December 10, 2019

Conditions

Lacrimal Duct Obstruction

Interventions

PROCEDURE

"pushed mono-canaliculonasal intubation"

Trial Locations (1)

75019

Fondation Ophtalmologique A. de Rothschild, Paris

All Listed Sponsors

lead

Fondation Ophtalmologique Adolphe de Rothschild

NETWORK

NCT02851641 - Risk and Importance of Peroperative Nasal Hemorrhage in the Treatment of Lacrimal Duct Obstruction in Young Children | Biotech Hunter | Biotech Hunter